Suicide versus Accidental Death by Autoerotic Asphyxiation in a Patient Receiving Intravenous Ketamine for Depression
CONCLUSIONS: Though we are uncertain about the patient's cause of death, this case provides an opportunity to highlight important gaps in our understanding of the suicide-related risks of subanesthetic intravenous ketamine treatment for mood disorders and suicidality.PMID:35528868 | PMC:PMC9072044 | DOI:10.1155/2022/1104668
Source: Case Reports in Psychiatry - Category: Psychiatry Authors: Jeremy Weleff Kelly Bryant Alexsandra Kovacevich Brian S Barnett Source Type: research
More News: ADHD | Anxiety | Autism | Clinical Trials | Depression | Disability | Generalized Anxiety Disorder (GAD) | Hyperactivity | Hypothyroidism | Low Testosterone | Obsessive Compulsive Disorder | Panic Disorder | Psychiatry | Psychology | Sleep Apnea | Sleep Disorders | Sleep Medicine | Suicide